Consensus Ryvu Therapeutics S.A.

Equities

RVU

PLSELVT00013

Market Closed - Warsaw S.E. Other stock markets 11:55:46 2024-05-17 am EDT			5-day change	1st Jan Change
55.8 ^PLN	+1.45%		+10.06%	-2.96%

May. 17	Transcript : Ryvu Therapeutics S.A. - Special Call
Mar. 13	Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Ryvu Therapeutics S.A.

Price target over the last 5 years

History of analyst recommendation changes

94ab8c35991dad34650c7.9CQHTokXqv-oENHt9llu_xurPw3x66vK9pyQ4mHfspg.knBqGMFH3JjEe4u7kQktk3rcaU_HrOaNna7FqwOy_PKwfl0a43LAzp8ptg~4e12cd6cb6201bbc5a832dd796f12e1c

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

55.8 PLN

Average target price

73.12 PLN

Spread / Average Target

+31.05%

High Price Target

80 PLN

Spread / Highest target

+43.37%

Low Price Target

64 PLN

Spread / Lowest Target

+14.70%

Consensus detail

Consensus revision (last 18 months)

Ratings for Ryvu Therapeutics S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Quarterly revenue - Rate of surprise

Company calendar